Condition: Breast Cancer · Sponsor: Fudan University
The study was designed to investigate whether hypofractionated adjuvant radiotherapy is noninferior to conventionally fractionated adjuvant radiotherapy in terms of efficacy and toxicities for high risk breast cancer patients treated with mastectomy
This description comes directly from the study's public registry record.
Jinli Ma, MD, PhD · +86-15221033376 · jinli.ma@aliyun.com
Xingxing Chen, MD, PhD · +86-13585547068 · xingxing@yahoo.com
Always discuss trial participation with your own doctor first.
| Suzhou Municipal hospital | Suzhou, Jiangsu, China | Not Yet Recruiting |
| Fudan University Shanghai Cancer Center | Shanghai, Shanghai Municipality, China | Recruiting |
| Huangpu Branch, Shanghai ninth people's hospital | Shanghai, Shanghai Municipality, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03856372